nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—SMO—Fluocinonide—atopic dermatitis	0.633	0.717	CbGbCtD
Vismodegib—ORM1—Tacrolimus—atopic dermatitis	0.0443	0.0502	CbGbCtD
Vismodegib—ALB—Tacrolimus—atopic dermatitis	0.0186	0.0211	CbGbCtD
Vismodegib—CYP2C8—Mometasone—atopic dermatitis	0.0184	0.0208	CbGbCtD
Vismodegib—ABCG2—Hydrocortisone—atopic dermatitis	0.011	0.0125	CbGbCtD
Vismodegib—CYP2C8—Loratadine—atopic dermatitis	0.0105	0.0119	CbGbCtD
Vismodegib—CYP3A4—Pimecrolimus—atopic dermatitis	0.00983	0.0111	CbGbCtD
Vismodegib—ABCB1—Tacrolimus—atopic dermatitis	0.00975	0.011	CbGbCtD
Vismodegib—CYP2C19—Diphenhydramine—atopic dermatitis	0.00885	0.01	CbGbCtD
Vismodegib—CYP2C19—Loratadine—atopic dermatitis	0.00885	0.01	CbGbCtD
Vismodegib—SHH—skin epidermis—atopic dermatitis	0.00775	0.53	CbGeAlD
Vismodegib—ALB—Prednisone—atopic dermatitis	0.00756	0.00857	CbGbCtD
Vismodegib—CYP2C9—Loratadine—atopic dermatitis	0.00736	0.00833	CbGbCtD
Vismodegib—CYP2C9—Diphenhydramine—atopic dermatitis	0.00736	0.00833	CbGbCtD
Vismodegib—ABCB1—Loratadine—atopic dermatitis	0.00714	0.00809	CbGbCtD
Vismodegib—ABCG2—Dexamethasone—atopic dermatitis	0.00685	0.00776	CbGbCtD
Vismodegib—ABCB1—Methylprednisolone—atopic dermatitis	0.00653	0.0074	CbGbCtD
Vismodegib—CYP2C8—Hydrocortisone—atopic dermatitis	0.00587	0.00664	CbGbCtD
Vismodegib—CYP3A4—Tacrolimus—atopic dermatitis	0.00584	0.00662	CbGbCtD
Vismodegib—CYP2C19—Prednisone—atopic dermatitis	0.0049	0.00555	CbGbCtD
Vismodegib—CYP3A4—Loratadine—atopic dermatitis	0.00428	0.00484	CbGbCtD
Vismodegib—ABCB1—Betamethasone—atopic dermatitis	0.00424	0.00481	CbGbCtD
Vismodegib—ABCB1—Prednisolone—atopic dermatitis	0.00419	0.00474	CbGbCtD
Vismodegib—ABCB1—Hydrocortisone—atopic dermatitis	0.00397	0.0045	CbGbCtD
Vismodegib—ABCB1—Prednisone—atopic dermatitis	0.00396	0.00448	CbGbCtD
Vismodegib—CYP3A4—Methylprednisolone—atopic dermatitis	0.00391	0.00443	CbGbCtD
Vismodegib—CYP2C8—Dexamethasone—atopic dermatitis	0.00365	0.00413	CbGbCtD
Vismodegib—CYP2C19—Dexamethasone—atopic dermatitis	0.00306	0.00347	CbGbCtD
Vismodegib—CYP3A4—Triamcinolone—atopic dermatitis	0.00296	0.00336	CbGbCtD
Vismodegib—CYP2C9—Dexamethasone—atopic dermatitis	0.00254	0.00288	CbGbCtD
Vismodegib—CYP3A4—Betamethasone—atopic dermatitis	0.00254	0.00288	CbGbCtD
Vismodegib—CYP3A4—Prednisolone—atopic dermatitis	0.00251	0.00284	CbGbCtD
Vismodegib—ABCB1—Dexamethasone—atopic dermatitis	0.00247	0.0028	CbGbCtD
Vismodegib—SHH—skin of body—atopic dermatitis	0.0024	0.164	CbGeAlD
Vismodegib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00238	0.00269	CbGbCtD
Vismodegib—CYP3A4—Prednisone—atopic dermatitis	0.00237	0.00268	CbGbCtD
Vismodegib—SMO—skin of body—atopic dermatitis	0.00168	0.115	CbGeAlD
Vismodegib—SHH—head—atopic dermatitis	0.00157	0.107	CbGeAlD
Vismodegib—SHH—Hedgehog signaling events mediated by Gli proteins—KIF3A—atopic dermatitis	0.00152	0.0679	CbGpPWpGaD
Vismodegib—CYP3A4—Dexamethasone—atopic dermatitis	0.00148	0.00168	CbGbCtD
Vismodegib—SMO—Hedgehog signaling events mediated by Gli proteins—KIF3A—atopic dermatitis	0.00144	0.0644	CbGpPWpGaD
Vismodegib—SHH—Glypican 3 network—MAPK8—atopic dermatitis	0.00137	0.0612	CbGpPWpGaD
Vismodegib—SMO—head—atopic dermatitis	0.0011	0.0749	CbGeAlD
Vismodegib—SMO—Hedgehog 'off' state—KIF3A—atopic dermatitis	0.000812	0.0364	CbGpPWpGaD
Vismodegib—SHH—Ectoderm Differentiation—GLB1—atopic dermatitis	0.000777	0.0348	CbGpPWpGaD
Vismodegib—SHH—Signaling by Hedgehog—KIF3A—atopic dermatitis	0.000764	0.0343	CbGpPWpGaD
Vismodegib—SMO—Signaling by Hedgehog—KIF3A—atopic dermatitis	0.000725	0.0325	CbGpPWpGaD
Vismodegib—SMO—GPCRs, Other—CXCR3—atopic dermatitis	0.000555	0.0249	CbGpPWpGaD
Vismodegib—Alopecia—Loratadine—atopic dermatitis	0.000494	0.00615	CcSEcCtD
Vismodegib—Connective tissue disorder—Fluocinolone Acetonide—atopic dermatitis	0.000493	0.00615	CcSEcCtD
Vismodegib—Pain—Fluocinonide—atopic dermatitis	0.000489	0.00609	CcSEcCtD
Vismodegib—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.000489	0.00609	CcSEcCtD
Vismodegib—Skin disorder—Pimecrolimus—atopic dermatitis	0.000484	0.00603	CcSEcCtD
Vismodegib—Dysgeusia—Loratadine—atopic dermatitis	0.000476	0.00593	CcSEcCtD
Vismodegib—Amenorrhoea—Betamethasone—atopic dermatitis	0.000461	0.00574	CcSEcCtD
Vismodegib—Amenorrhoea—Dexamethasone—atopic dermatitis	0.000461	0.00574	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.000454	0.00566	CcSEcCtD
Vismodegib—Dyspepsia—Diphenhydramine—atopic dermatitis	0.000454	0.00565	CcSEcCtD
Vismodegib—Dyspepsia—Dimenhydrinate—atopic dermatitis	0.000454	0.00565	CcSEcCtD
Vismodegib—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.000448	0.00558	CcSEcCtD
Vismodegib—Decreased appetite—Diphenhydramine—atopic dermatitis	0.000448	0.00558	CcSEcCtD
Vismodegib—Rash—Desonide—atopic dermatitis	0.000445	0.00554	CcSEcCtD
Vismodegib—Dermatitis—Desonide—atopic dermatitis	0.000444	0.00554	CcSEcCtD
Vismodegib—Fatigue—Diphenhydramine—atopic dermatitis	0.000444	0.00554	CcSEcCtD
Vismodegib—Fatigue—Dimenhydrinate—atopic dermatitis	0.000444	0.00554	CcSEcCtD
Vismodegib—Alopecia—Fluocinolone Acetonide—atopic dermatitis	0.000444	0.00553	CcSEcCtD
Vismodegib—Constipation—Diphenhydramine—atopic dermatitis	0.000441	0.00549	CcSEcCtD
Vismodegib—Constipation—Dimenhydrinate—atopic dermatitis	0.000441	0.00549	CcSEcCtD
Vismodegib—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.000437	0.00545	CcSEcCtD
Vismodegib—Weight decreased—Tacrolimus—atopic dermatitis	0.000431	0.00537	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00043	0.00536	CcSEcCtD
Vismodegib—Dysgeusia—Fluocinolone Acetonide—atopic dermatitis	0.000428	0.00533	CcSEcCtD
Vismodegib—Constipation—Pimecrolimus—atopic dermatitis	0.000426	0.00531	CcSEcCtD
Vismodegib—Pain—Pimecrolimus—atopic dermatitis	0.000426	0.00531	CcSEcCtD
Vismodegib—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.000423	0.00527	CcSEcCtD
Vismodegib—Myalgia—Loratadine—atopic dermatitis	0.000414	0.00516	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.000411	0.00512	CcSEcCtD
Vismodegib—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.000408	0.00508	CcSEcCtD
Vismodegib—Pruritus—Fluocinonide—atopic dermatitis	0.000404	0.00504	CcSEcCtD
Vismodegib—Back pain—Mometasone—atopic dermatitis	0.000404	0.00503	CcSEcCtD
Vismodegib—Amenorrhoea—Prednisone—atopic dermatitis	0.000401	0.005	CcSEcCtD
Vismodegib—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000394	0.00491	CcSEcCtD
Vismodegib—Nervous system disorder—Loratadine—atopic dermatitis	0.000389	0.00485	CcSEcCtD
Vismodegib—Skin disorder—Loratadine—atopic dermatitis	0.000386	0.0048	CcSEcCtD
Vismodegib—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.000375	0.00467	CcSEcCtD
Vismodegib—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.000372	0.00464	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Methylprednisolone—atopic dermatitis	0.000372	0.00463	CcSEcCtD
Vismodegib—Asthenia—Dimenhydrinate—atopic dermatitis	0.00037	0.00461	CcSEcCtD
Vismodegib—Asthenia—Diphenhydramine—atopic dermatitis	0.00037	0.00461	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.000362	0.00451	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCL22—atopic dermatitis	0.000362	0.0162	CbGpPWpGaD
Vismodegib—Rash—Fluocinonide—atopic dermatitis	0.00036	0.00449	CcSEcCtD
Vismodegib—Dermatitis—Fluocinonide—atopic dermatitis	0.00036	0.00449	CcSEcCtD
Vismodegib—Myalgia—Mometasone—atopic dermatitis	0.000355	0.00443	CcSEcCtD
Vismodegib—Arthralgia—Mometasone—atopic dermatitis	0.000355	0.00443	CcSEcCtD
Vismodegib—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000353	0.00439	CcSEcCtD
Vismodegib—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000353	0.00439	CcSEcCtD
Vismodegib—Pruritus—Pimecrolimus—atopic dermatitis	0.000353	0.00439	CcSEcCtD
Vismodegib—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00035	0.00436	CcSEcCtD
Vismodegib—Dyspepsia—Loratadine—atopic dermatitis	0.000349	0.00435	CcSEcCtD
Vismodegib—SMO—GPCRs, Other—CCR5—atopic dermatitis	0.000348	0.0156	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CCL22—atopic dermatitis	0.000343	0.0154	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000343	0.00427	CcSEcCtD
Vismodegib—Fatigue—Loratadine—atopic dermatitis	0.000342	0.00426	CcSEcCtD
Vismodegib—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000341	0.00425	CcSEcCtD
Vismodegib—Constipation—Loratadine—atopic dermatitis	0.000339	0.00423	CcSEcCtD
Vismodegib—Pain—Loratadine—atopic dermatitis	0.000339	0.00423	CcSEcCtD
Vismodegib—Alopecia—Tacrolimus—atopic dermatitis	0.000337	0.0042	CcSEcCtD
Vismodegib—Malnutrition—Tacrolimus—atopic dermatitis	0.000332	0.00414	CcSEcCtD
Vismodegib—Vomiting—Diphenhydramine—atopic dermatitis	0.000328	0.00408	CcSEcCtD
Vismodegib—Vomiting—Dimenhydrinate—atopic dermatitis	0.000328	0.00408	CcSEcCtD
Vismodegib—Dysgeusia—Tacrolimus—atopic dermatitis	0.000325	0.00405	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000325	0.00405	CcSEcCtD
Vismodegib—Rash—Diphenhydramine—atopic dermatitis	0.000325	0.00405	CcSEcCtD
Vismodegib—Rash—Dimenhydrinate—atopic dermatitis	0.000325	0.00405	CcSEcCtD
Vismodegib—Dermatitis—Diphenhydramine—atopic dermatitis	0.000325	0.00404	CcSEcCtD
Vismodegib—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000325	0.00404	CcSEcCtD
Vismodegib—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000325	0.00404	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCL27—atopic dermatitis	0.000322	0.0144	CbGpPWpGaD
Vismodegib—Back pain—Tacrolimus—atopic dermatitis	0.000321	0.004	CcSEcCtD
Vismodegib—Muscle spasms—Tacrolimus—atopic dermatitis	0.000319	0.00398	CcSEcCtD
Vismodegib—Vomiting—Pimecrolimus—atopic dermatitis	0.000317	0.00395	CcSEcCtD
Vismodegib—Abdominal pain upper—Hydrocortisone—atopic dermatitis	0.000314	0.00392	CcSEcCtD
Vismodegib—Rash—Pimecrolimus—atopic dermatitis	0.000314	0.00391	CcSEcCtD
Vismodegib—Dermatitis—Pimecrolimus—atopic dermatitis	0.000314	0.00391	CcSEcCtD
Vismodegib—Abdominal pain—Loratadine—atopic dermatitis	0.000314	0.00391	CcSEcCtD
Vismodegib—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.000313	0.0039	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.00031	0.00387	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000308	0.00384	CcSEcCtD
Vismodegib—Nausea—Dimenhydrinate—atopic dermatitis	0.000306	0.00381	CcSEcCtD
Vismodegib—Nausea—Diphenhydramine—atopic dermatitis	0.000306	0.00381	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—CCL27—atopic dermatitis	0.000306	0.0137	CbGpPWpGaD
Vismodegib—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000305	0.0038	CcSEcCtD
Vismodegib—Dyspepsia—Mometasone—atopic dermatitis	0.0003	0.00374	CcSEcCtD
Vismodegib—Decreased appetite—Mometasone—atopic dermatitis	0.000296	0.00369	CcSEcCtD
Vismodegib—Nausea—Pimecrolimus—atopic dermatitis	0.000296	0.00369	CcSEcCtD
Vismodegib—Fatigue—Mometasone—atopic dermatitis	0.000294	0.00366	CcSEcCtD
Vismodegib—Breast disorder—Methylprednisolone—atopic dermatitis	0.000292	0.00364	CcSEcCtD
Vismodegib—Pain—Mometasone—atopic dermatitis	0.000291	0.00363	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCL17—atopic dermatitis	0.000289	0.013	CbGpPWpGaD
Vismodegib—Asthenia—Loratadine—atopic dermatitis	0.000285	0.00355	CcSEcCtD
Vismodegib—Arthralgia—Tacrolimus—atopic dermatitis	0.000283	0.00352	CcSEcCtD
Vismodegib—Myalgia—Tacrolimus—atopic dermatitis	0.000283	0.00352	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000281	0.0035	CcSEcCtD
Vismodegib—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000279	0.00347	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—CCL17—atopic dermatitis	0.000274	0.0123	CbGpPWpGaD
Vismodegib—Diarrhoea—Loratadine—atopic dermatitis	0.000272	0.00338	CcSEcCtD
Vismodegib—Abdominal pain—Mometasone—atopic dermatitis	0.000269	0.00335	CcSEcCtD
Vismodegib—Weight decreased—Hydrocortisone—atopic dermatitis	0.000269	0.00335	CcSEcCtD
Vismodegib—Hypokalaemia—Betamethasone—atopic dermatitis	0.000268	0.00333	CcSEcCtD
Vismodegib—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000268	0.00333	CcSEcCtD
Vismodegib—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000266	0.00331	CcSEcCtD
Vismodegib—Skin disorder—Tacrolimus—atopic dermatitis	0.000263	0.00328	CcSEcCtD
Vismodegib—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000252	0.00314	CcSEcCtD
Vismodegib—Vomiting—Loratadine—atopic dermatitis	0.000252	0.00314	CcSEcCtD
Vismodegib—Rash—Loratadine—atopic dermatitis	0.00025	0.00312	CcSEcCtD
Vismodegib—Dermatitis—Loratadine—atopic dermatitis	0.00025	0.00312	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000247	0.00308	CcSEcCtD
Vismodegib—Asthenia—Mometasone—atopic dermatitis	0.000244	0.00304	CcSEcCtD
Vismodegib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000244	0.00304	CcSEcCtD
Vismodegib—Pruritus—Mometasone—atopic dermatitis	0.000241	0.003	CcSEcCtD
Vismodegib—Dyspepsia—Tacrolimus—atopic dermatitis	0.000239	0.00297	CcSEcCtD
Vismodegib—Nausea—Loratadine—atopic dermatitis	0.000236	0.00294	CcSEcCtD
Vismodegib—Decreased appetite—Tacrolimus—atopic dermatitis	0.000236	0.00294	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000235	0.0105	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000234	0.00292	CcSEcCtD
Vismodegib—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000234	0.00291	CcSEcCtD
Vismodegib—Fatigue—Tacrolimus—atopic dermatitis	0.000234	0.00291	CcSEcCtD
Vismodegib—Diarrhoea—Mometasone—atopic dermatitis	0.000233	0.0029	CcSEcCtD
Vismodegib—Hypokalaemia—Prednisone—atopic dermatitis	0.000233	0.0029	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCL11—atopic dermatitis	0.000233	0.0104	CbGpPWpGaD
Vismodegib—Pain—Tacrolimus—atopic dermatitis	0.000232	0.00289	CcSEcCtD
Vismodegib—Constipation—Tacrolimus—atopic dermatitis	0.000232	0.00289	CcSEcCtD
Vismodegib—Weight decreased—Betamethasone—atopic dermatitis	0.00023	0.00286	CcSEcCtD
Vismodegib—Weight decreased—Dexamethasone—atopic dermatitis	0.00023	0.00286	CcSEcCtD
Vismodegib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000227	0.00283	CcSEcCtD
Vismodegib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000225	0.0028	CcSEcCtD
Vismodegib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000225	0.0028	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000223	0.00998	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000222	0.00276	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—CCL11—atopic dermatitis	0.000221	0.0099	CbGpPWpGaD
Vismodegib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.00022	0.00274	CcSEcCtD
Vismodegib—Vomiting—Mometasone—atopic dermatitis	0.000217	0.0027	CcSEcCtD
Vismodegib—Rash—Mometasone—atopic dermatitis	0.000215	0.00268	CcSEcCtD
Vismodegib—Dermatitis—Mometasone—atopic dermatitis	0.000215	0.00267	CcSEcCtD
Vismodegib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000214	0.00267	CcSEcCtD
Vismodegib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000212	0.00264	CcSEcCtD
Vismodegib—SHH—Differentiation Pathway—IL6—atopic dermatitis	0.000208	0.00932	CbGpPWpGaD
Vismodegib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000207	0.00258	CcSEcCtD
Vismodegib—Nausea—Mometasone—atopic dermatitis	0.000202	0.00252	CcSEcCtD
Vismodegib—Weight decreased—Prednisone—atopic dermatitis	0.0002	0.00249	CcSEcCtD
Vismodegib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000195	0.00243	CcSEcCtD
Vismodegib—Asthenia—Tacrolimus—atopic dermatitis	0.000195	0.00242	CcSEcCtD
Vismodegib—Pruritus—Tacrolimus—atopic dermatitis	0.000192	0.00239	CcSEcCtD
Vismodegib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000191	0.00238	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCR3—atopic dermatitis	0.00019	0.00851	CbGpPWpGaD
Vismodegib—Back pain—Triamcinolone—atopic dermatitis	0.000189	0.00235	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—CCL22—atopic dermatitis	0.000186	0.00831	CbGpPWpGaD
Vismodegib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000186	0.00231	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—CCR3—atopic dermatitis	0.00018	0.00807	CbGpPWpGaD
Vismodegib—Alopecia—Dexamethasone—atopic dermatitis	0.00018	0.00224	CcSEcCtD
Vismodegib—Alopecia—Betamethasone—atopic dermatitis	0.00018	0.00224	CcSEcCtD
Vismodegib—Myalgia—Hydrocortisone—atopic dermatitis	0.000176	0.0022	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—CCL22—atopic dermatitis	0.000176	0.00788	CbGpPWpGaD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000175	0.00218	CcSEcCtD
Vismodegib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000174	0.00217	CcSEcCtD
Vismodegib—Vomiting—Tacrolimus—atopic dermatitis	0.000172	0.00215	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000172	0.00771	CbGpPWpGaD
Vismodegib—Rash—Tacrolimus—atopic dermatitis	0.000171	0.00213	CcSEcCtD
Vismodegib—Dermatitis—Tacrolimus—atopic dermatitis	0.000171	0.00213	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—TAC1—atopic dermatitis	0.000169	0.00759	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—NPS—atopic dermatitis	0.000169	0.00759	CbGpPWpGaD
Vismodegib—Myalgia—Triamcinolone—atopic dermatitis	0.000166	0.00207	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CXCR3—atopic dermatitis	0.000166	0.00744	CbGpPWpGaD
Vismodegib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000166	0.00207	CcSEcCtD
Vismodegib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000166	0.00207	CcSEcCtD
Vismodegib—Myalgia—Methylprednisolone—atopic dermatitis	0.000166	0.00207	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—CCL27—atopic dermatitis	0.000165	0.00741	CbGpPWpGaD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000165	0.00205	CcSEcCtD
Vismodegib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000164	0.00205	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000163	0.00731	CbGpPWpGaD
Vismodegib—Nausea—Tacrolimus—atopic dermatitis	0.000161	0.00201	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—NPS—atopic dermatitis	0.00016	0.00719	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—TAC1—atopic dermatitis	0.00016	0.00719	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CXCR3—atopic dermatitis	0.000157	0.00705	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCL27—atopic dermatitis	0.000157	0.00703	CbGpPWpGaD
Vismodegib—Alopecia—Prednisone—atopic dermatitis	0.000157	0.00195	CcSEcCtD
Vismodegib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000156	0.00194	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000155	0.00695	CbGpPWpGaD
Vismodegib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000154	0.00192	CcSEcCtD
Vismodegib—Malnutrition—Prednisone—atopic dermatitis	0.000154	0.00192	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000154	0.00192	CcSEcCtD
Vismodegib—Myalgia—Dexamethasone—atopic dermatitis	0.000151	0.00188	CcSEcCtD
Vismodegib—Myalgia—Betamethasone—atopic dermatitis	0.000151	0.00188	CcSEcCtD
Vismodegib—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000149	0.00185	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—CCL17—atopic dermatitis	0.000148	0.00665	CbGpPWpGaD
Vismodegib—Pain—Prednisolone—atopic dermatitis	0.000148	0.00184	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000147	0.00659	CbGpPWpGaD
Vismodegib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000147	0.00183	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000146	0.00182	CcSEcCtD
Vismodegib—Fatigue—Hydrocortisone—atopic dermatitis	0.000146	0.00182	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000145	0.00181	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000145	0.0018	CcSEcCtD
Vismodegib—Pain—Hydrocortisone—atopic dermatitis	0.000145	0.0018	CcSEcCtD
Vismodegib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000142	0.00177	CcSEcCtD
Vismodegib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000142	0.00177	CcSEcCtD
Vismodegib—ABCB1—head—atopic dermatitis	0.000142	0.00967	CbGeAlD
Vismodegib—SMO—Signaling by GPCR—CCL17—atopic dermatitis	0.000141	0.0063	CbGpPWpGaD
Vismodegib—Dyspepsia—Triamcinolone—atopic dermatitis	0.00014	0.00175	CcSEcCtD
Vismodegib—Dyspepsia—Methylprednisolone—atopic dermatitis	0.00014	0.00174	CcSEcCtD
Vismodegib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000138	0.00172	CcSEcCtD
Vismodegib—Fatigue—Triamcinolone—atopic dermatitis	0.000137	0.00171	CcSEcCtD
Vismodegib—Fatigue—Methylprednisolone—atopic dermatitis	0.000137	0.00171	CcSEcCtD
Vismodegib—Pain—Triamcinolone—atopic dermatitis	0.000136	0.0017	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CXCL10—atopic dermatitis	0.000134	0.00601	CbGpPWpGaD
Vismodegib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000134	0.00167	CcSEcCtD
Vismodegib—SHH—Disease—GLB1—atopic dermatitis	0.000133	0.00596	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000132	0.00164	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000132	0.00164	CcSEcCtD
Vismodegib—Arthralgia—Prednisone—atopic dermatitis	0.000131	0.00164	CcSEcCtD
Vismodegib—Myalgia—Prednisone—atopic dermatitis	0.000131	0.00164	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.00013	0.00162	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.00013	0.00162	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—CXCL10—atopic dermatitis	0.000127	0.0057	CbGpPWpGaD
Vismodegib—Dyspepsia—Dexamethasone—atopic dermatitis	0.000127	0.00158	CcSEcCtD
Vismodegib—Dyspepsia—Betamethasone—atopic dermatitis	0.000127	0.00158	CcSEcCtD
Vismodegib—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000126	0.00156	CcSEcCtD
Vismodegib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000126	0.00156	CcSEcCtD
Vismodegib—Decreased appetite—Betamethasone—atopic dermatitis	0.000126	0.00156	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000125	0.00155	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000125	0.00155	CcSEcCtD
Vismodegib—Fatigue—Dexamethasone—atopic dermatitis	0.000125	0.00155	CcSEcCtD
Vismodegib—Fatigue—Betamethasone—atopic dermatitis	0.000125	0.00155	CcSEcCtD
Vismodegib—Pain—Dexamethasone—atopic dermatitis	0.000124	0.00154	CcSEcCtD
Vismodegib—Pain—Betamethasone—atopic dermatitis	0.000124	0.00154	CcSEcCtD
Vismodegib—Nervous system disorder—Prednisone—atopic dermatitis	0.000123	0.00154	CcSEcCtD
Vismodegib—Skin disorder—Prednisone—atopic dermatitis	0.000122	0.00152	CcSEcCtD
Vismodegib—Asthenia—Hydrocortisone—atopic dermatitis	0.000121	0.00151	CcSEcCtD
Vismodegib—Pruritus—Hydrocortisone—atopic dermatitis	0.00012	0.00149	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—CCL11—atopic dermatitis	0.00012	0.00536	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000118	0.00147	CcSEcCtD
Vismodegib—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000118	0.00147	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—FCER2—atopic dermatitis	0.000118	0.00528	CbGpPWpGaD
Vismodegib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000116	0.00144	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCL5—atopic dermatitis	0.000116	0.00518	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000115	0.00143	CcSEcCtD
Vismodegib—Asthenia—Triamcinolone—atopic dermatitis	0.000114	0.00142	CcSEcCtD
Vismodegib—Abdominal pain—Dexamethasone—atopic dermatitis	0.000114	0.00142	CcSEcCtD
Vismodegib—Abdominal pain—Betamethasone—atopic dermatitis	0.000114	0.00142	CcSEcCtD
Vismodegib—Asthenia—Methylprednisolone—atopic dermatitis	0.000114	0.00142	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—CCL11—atopic dermatitis	0.000113	0.00508	CbGpPWpGaD
Vismodegib—Pruritus—Triamcinolone—atopic dermatitis	0.000113	0.0014	CcSEcCtD
Vismodegib—Pruritus—Methylprednisolone—atopic dermatitis	0.000112	0.0014	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—FCER2—atopic dermatitis	0.000112	0.00501	CbGpPWpGaD
Vismodegib—Dyspepsia—Prednisone—atopic dermatitis	0.000111	0.00138	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—CCL22—atopic dermatitis	0.00011	0.00491	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CCL5—atopic dermatitis	0.00011	0.00491	CbGpPWpGaD
Vismodegib—Decreased appetite—Prednisone—atopic dermatitis	0.000109	0.00136	CcSEcCtD
Vismodegib—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000109	0.0049	CbGpPWpGaD
Vismodegib—Rash—Prednisolone—atopic dermatitis	0.000109	0.00136	CcSEcCtD
Vismodegib—Dermatitis—Prednisolone—atopic dermatitis	0.000109	0.00136	CcSEcCtD
Vismodegib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000109	0.00135	CcSEcCtD
Vismodegib—Fatigue—Prednisone—atopic dermatitis	0.000109	0.00135	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.000108	0.00484	CbGpPWpGaD
Vismodegib—Constipation—Prednisone—atopic dermatitis	0.000108	0.00134	CcSEcCtD
Vismodegib—Vomiting—Hydrocortisone—atopic dermatitis	0.000108	0.00134	CcSEcCtD
Vismodegib—Rash—Hydrocortisone—atopic dermatitis	0.000107	0.00133	CcSEcCtD
Vismodegib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000107	0.00133	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—CCR5—atopic dermatitis	0.000104	0.00466	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL22—atopic dermatitis	0.000104	0.00466	CbGpPWpGaD
Vismodegib—Asthenia—Dexamethasone—atopic dermatitis	0.000104	0.00129	CcSEcCtD
Vismodegib—Asthenia—Betamethasone—atopic dermatitis	0.000104	0.00129	CcSEcCtD
Vismodegib—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000103	0.00463	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000103	0.00128	CcSEcCtD
Vismodegib—Nausea—Prednisolone—atopic dermatitis	0.000103	0.00128	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.000102	0.00458	CbGpPWpGaD
Vismodegib—Pruritus—Betamethasone—atopic dermatitis	0.000102	0.00127	CcSEcCtD
Vismodegib—Pruritus—Dexamethasone—atopic dermatitis	0.000102	0.00127	CcSEcCtD
Vismodegib—Vomiting—Triamcinolone—atopic dermatitis	0.000101	0.00126	CcSEcCtD
Vismodegib—Vomiting—Methylprednisolone—atopic dermatitis	0.000101	0.00126	CcSEcCtD
Vismodegib—Nausea—Hydrocortisone—atopic dermatitis	0.0001	0.00125	CcSEcCtD
Vismodegib—Rash—Triamcinolone—atopic dermatitis	0.0001	0.00125	CcSEcCtD
Vismodegib—Dermatitis—Triamcinolone—atopic dermatitis	0.0001	0.00125	CcSEcCtD
Vismodegib—Rash—Methylprednisolone—atopic dermatitis	0.0001	0.00125	CcSEcCtD
Vismodegib—Dermatitis—Methylprednisolone—atopic dermatitis	0.0001	0.00125	CcSEcCtD
Vismodegib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.96e-05	0.00446	CbGpPWpGaD
Vismodegib—Abdominal pain—Prednisone—atopic dermatitis	9.95e-05	0.00124	CcSEcCtD
Vismodegib—Diarrhoea—Betamethasone—atopic dermatitis	9.89e-05	0.00123	CcSEcCtD
Vismodegib—Diarrhoea—Dexamethasone—atopic dermatitis	9.89e-05	0.00123	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—CCR5—atopic dermatitis	9.87e-05	0.00442	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL27—atopic dermatitis	9.77e-05	0.00438	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CCR3—atopic dermatitis	9.75e-05	0.00437	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—CCL5—atopic dermatitis	9.51e-05	0.00426	CbGpPWpGaD
Vismodegib—Nausea—Triamcinolone—atopic dermatitis	9.46e-05	0.00118	CcSEcCtD
Vismodegib—Nausea—Methylprednisolone—atopic dermatitis	9.44e-05	0.00118	CcSEcCtD
Vismodegib—ABCB1—Allograft Rejection—IL13—atopic dermatitis	9.35e-05	0.00419	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.3e-05	0.00417	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL27—atopic dermatitis	9.26e-05	0.00415	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCR3—atopic dermatitis	9.24e-05	0.00414	CbGpPWpGaD
Vismodegib—Vomiting—Dexamethasone—atopic dermatitis	9.19e-05	0.00114	CcSEcCtD
Vismodegib—Vomiting—Betamethasone—atopic dermatitis	9.19e-05	0.00114	CcSEcCtD
Vismodegib—Rash—Betamethasone—atopic dermatitis	9.11e-05	0.00114	CcSEcCtD
Vismodegib—Rash—Dexamethasone—atopic dermatitis	9.11e-05	0.00114	CcSEcCtD
Vismodegib—Dermatitis—Betamethasone—atopic dermatitis	9.1e-05	0.00113	CcSEcCtD
Vismodegib—Dermatitis—Dexamethasone—atopic dermatitis	9.1e-05	0.00113	CcSEcCtD
Vismodegib—Asthenia—Prednisone—atopic dermatitis	9.03e-05	0.00112	CcSEcCtD
Vismodegib—SHH—Disease—SLC11A1—atopic dermatitis	8.92e-05	0.004	CbGpPWpGaD
Vismodegib—Pruritus—Prednisone—atopic dermatitis	8.9e-05	0.00111	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—CCL17—atopic dermatitis	8.76e-05	0.00393	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—NPS—atopic dermatitis	8.69e-05	0.00389	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—TAC1—atopic dermatitis	8.69e-05	0.00389	CbGpPWpGaD
Vismodegib—Diarrhoea—Prednisone—atopic dermatitis	8.61e-05	0.00107	CcSEcCtD
Vismodegib—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	8.61e-05	0.00386	CbGpPWpGaD
Vismodegib—Nausea—Dexamethasone—atopic dermatitis	8.58e-05	0.00107	CcSEcCtD
Vismodegib—Nausea—Betamethasone—atopic dermatitis	8.58e-05	0.00107	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	8.54e-05	0.00383	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCR3—atopic dermatitis	8.52e-05	0.00382	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL17—atopic dermatitis	8.31e-05	0.00372	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—NPS—atopic dermatitis	8.24e-05	0.00369	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—TAC1—atopic dermatitis	8.24e-05	0.00369	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	8.09e-05	0.00363	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL5—atopic dermatitis	8.08e-05	0.00362	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCR3—atopic dermatitis	8.08e-05	0.00362	CbGpPWpGaD
Vismodegib—Vomiting—Prednisone—atopic dermatitis	8e-05	0.000997	CcSEcCtD
Vismodegib—ABCB1—Allograft Rejection—IL5—atopic dermatitis	8e-05	0.00358	CbGpPWpGaD
Vismodegib—Rash—Prednisone—atopic dermatitis	7.94e-05	0.000989	CcSEcCtD
Vismodegib—Dermatitis—Prednisone—atopic dermatitis	7.93e-05	0.000988	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—KIF3A—atopic dermatitis	7.81e-05	0.0035	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL5—atopic dermatitis	7.66e-05	0.00343	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL4—atopic dermatitis	7.5e-05	0.00336	CbGpPWpGaD
Vismodegib—Nausea—Prednisone—atopic dermatitis	7.48e-05	0.000931	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—KIF3A—atopic dermatitis	7.4e-05	0.00332	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL11—atopic dermatitis	7.06e-05	0.00317	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CMA1—atopic dermatitis	7.06e-05	0.00317	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCL10—atopic dermatitis	6.89e-05	0.00309	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL11—atopic dermatitis	6.7e-05	0.003	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CMA1—atopic dermatitis	6.7e-05	0.003	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—STAT6—atopic dermatitis	6.64e-05	0.00298	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCL10—atopic dermatitis	6.53e-05	0.00293	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.38e-05	0.00286	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—STAT6—atopic dermatitis	6.3e-05	0.00282	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—CXCL8—atopic dermatitis	6.29e-05	0.00282	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.13e-05	0.00275	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CXCL8—atopic dermatitis	5.96e-05	0.00267	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CCL5—atopic dermatitis	5.93e-05	0.00266	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL10—atopic dermatitis	5.85e-05	0.00262	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCR3—atopic dermatitis	5.76e-05	0.00258	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL4—atopic dermatitis	5.69e-05	0.00255	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCL5—atopic dermatitis	5.62e-05	0.00252	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.59e-05	0.0025	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	5.57e-05	0.0025	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCR3—atopic dermatitis	5.46e-05	0.00245	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CCR5—atopic dermatitis	5.34e-05	0.00239	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TAC1—atopic dermatitis	5.13e-05	0.0023	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NPS—atopic dermatitis	5.13e-05	0.0023	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CCR5—atopic dermatitis	5.06e-05	0.00227	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCR3—atopic dermatitis	5.03e-05	0.00226	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	4.97e-05	0.00223	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NPS—atopic dermatitis	4.87e-05	0.00218	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TAC1—atopic dermatitis	4.87e-05	0.00218	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL5—atopic dermatitis	4.77e-05	0.00214	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCR3—atopic dermatitis	4.77e-05	0.00214	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	4.61e-05	0.00206	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IFNG—atopic dermatitis	4.53e-05	0.00203	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL5—atopic dermatitis	4.52e-05	0.00203	CbGpPWpGaD
Vismodegib—SHH—Disease—CCR5—atopic dermatitis	4.51e-05	0.00202	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCL10—atopic dermatitis	4.07e-05	0.00182	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	4.05e-05	0.00181	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL1B—atopic dermatitis	4.04e-05	0.00181	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL2—atopic dermatitis	4.03e-05	0.00181	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	4.01e-05	0.0018	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCL10—atopic dermatitis	3.86e-05	0.00173	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.79e-05	0.0017	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.7e-05	0.00166	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.68e-05	0.00165	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	3.61e-05	0.00162	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	3.6e-05	0.00161	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL5—atopic dermatitis	3.5e-05	0.00157	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	3.44e-05	0.00154	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KIF3A—atopic dermatitis	3.38e-05	0.00152	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL5—atopic dermatitis	3.32e-05	0.00149	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.3e-05	0.00148	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NGF—atopic dermatitis	3.24e-05	0.00145	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCL8—atopic dermatitis	3.23e-05	0.00145	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.21e-05	0.00144	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	3.2e-05	0.00143	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCR5—atopic dermatitis	3.16e-05	0.00141	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL2—atopic dermatitis	3.09e-05	0.00138	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NGF—atopic dermatitis	3.07e-05	0.00138	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	3.07e-05	0.00137	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCL8—atopic dermatitis	3.06e-05	0.00137	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL2—atopic dermatitis	3.06e-05	0.00137	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.02e-05	0.00135	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.01e-05	0.00135	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCR5—atopic dermatitis	2.99e-05	0.00134	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—atopic dermatitis	2.93e-05	0.00131	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL2—atopic dermatitis	2.93e-05	0.00131	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	2.91e-05	0.0013	CbGpPWpGaD
Vismodegib—SHH—Disease—CD4—atopic dermatitis	2.83e-05	0.00127	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SELE—atopic dermatitis	2.73e-05	0.00122	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NFKBIA—atopic dermatitis	2.67e-05	0.0012	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GLB1—atopic dermatitis	2.65e-05	0.00119	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ADSL—atopic dermatitis	2.54e-05	0.00114	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NFKBIA—atopic dermatitis	2.54e-05	0.00114	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL6—atopic dermatitis	2.37e-05	0.00106	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.34e-05	0.00105	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	2.33e-05	0.00104	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.23e-05	0.000998	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.21e-05	0.000992	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL5—atopic dermatitis	2.07e-05	0.000926	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.05e-05	0.000919	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2e-05	0.000895	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCL8—atopic dermatitis	1.91e-05	0.000855	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	1.88e-05	0.000843	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.84e-05	0.000824	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL2—atopic dermatitis	1.82e-05	0.000817	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—atopic dermatitis	1.81e-05	0.000813	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCL8—atopic dermatitis	1.81e-05	0.00081	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL2—atopic dermatitis	1.73e-05	0.000774	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—atopic dermatitis	1.72e-05	0.00077	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAPK8—atopic dermatitis	1.68e-05	0.000752	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GLB1—atopic dermatitis	1.65e-05	0.000738	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GLB1—atopic dermatitis	1.64e-05	0.000733	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAPK8—atopic dermatitis	1.59e-05	0.000713	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADSL—atopic dermatitis	1.58e-05	0.000707	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADSL—atopic dermatitis	1.57e-05	0.000703	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.53e-05	0.000686	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—atopic dermatitis	1.53e-05	0.000686	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GLB1—atopic dermatitis	1.47e-05	0.000658	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GLB1—atopic dermatitis	1.43e-05	0.000643	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.41e-05	0.000631	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.39e-05	0.000622	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADSL—atopic dermatitis	1.38e-05	0.000616	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.34e-05	0.0006	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.28e-05	0.000576	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.2e-05	0.000538	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.19e-05	0.000535	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.13e-05	0.000508	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.1e-05	0.000492	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—atopic dermatitis	1.07e-05	0.00048	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.07e-05	0.00048	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—atopic dermatitis	1.02e-05	0.000455	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.94e-06	0.000445	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.76e-06	0.000438	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.84e-06	0.000396	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARA—atopic dermatitis	8.61e-06	0.000386	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.47e-06	0.00038	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—atopic dermatitis	7.9e-06	0.000354	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARA—atopic dermatitis	5.34e-06	0.000239	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARA—atopic dermatitis	5.31e-06	0.000238	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARA—atopic dermatitis	4.77e-06	0.000214	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARA—atopic dermatitis	4.65e-06	0.000209	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARA—atopic dermatitis	4.35e-06	0.000195	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.87e-06	0.000129	CbGpPWpGaD
